• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Molecular Diagnostics for Inherited Disease Testing: Testing volume, cost per test, and market potential

$995.00 – $1,990.00

Clear
SKU: KLI1037842 Categories: Diagnostics Market Research, Molecular & Nucleic Acid Testing Pages: 140
  • Description
  • Table of Contents
  • Latest reports

Description

Gene and chromosome testing for inherited diseases currently represents the third largest molecular diagnostics testing segment in the U.S. Assays in this market address applications in genetic carrier and predisposition testing. Currently, most testing is for prenatal screening and for assessing clinically suspect newborns for various chromosomal abnormalities (e.g., Down’s syndrome, fragile X syndrome). Some testing is used for genetic counseling for couples planning to have children. Such diagnostics test for the presence of carrier states of diseases such as Tay-Sachs disease, sickle-cell anemia, or cystic fibrosis, where a clinical history of these disease conditions exists in their families. Another type of genetic and chromosomal molecular diagnostic testing is that for disease susceptibility, though this is not a major market factor at this time.

This summary report, extracted from Kalorama Information’s U.S. Market for Molecular Diagnostics, (2nd Edition, May 2004), focuses on the technologies and application of molecular diagnostics in the field of inherited disease testing.

The major market effects of new diagnostics—with the potential of a breakthrough product always a possibility—are being seen and are expected to significantly impact the market over the next ten years. The technology trends selected in conjunction with the growing interest in molecular diagnostics and their application to current health priorities (e.g., HIV/AIDS, cancer, sexually transmitted diseases, etc.) present the most informative picture of advances in this field and the markets that result. Market analysis considers various infectious disease diagnostic applications of molecular testing rather than the markets for specific technologies in the U.S. This report does not consider instrumentation, such as thermocyclers, luminometers, sequencers, etc. and their disposable support products. Some mention is made of such instrumentation, but greater emphasis is placed on applications and the technologies that will address those specific applications. The focus of the report is on molecular diagnostics technologies and products with the potential to become first-line methods for use in the clinical laboratory for inherited disease testing, and not for research or genomic data collection and cataloguing. The analysis presented in this report is based on data from a combination of company, government, industry, and institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including molecular biologists, laboratory medicine professionals, pathologists, research scientists, business development managers and marketing managers.

Table of Contents

Overview

Scope and Methodology

Market Context

Exhibit 1: Distribution of Molecular Diagnostics Testing in U.S. 2004

Inherited Disease Testing: Targets and Trends

Exhibit 2: Key Hereditary Diseases: SNP-Related

Exhibit 3: Key Hereditary Diseases: Chromosomal

Products of Note (Home-Brew Testing)

Exhibit 4: Key Home-Brew Molecular Diagnostics Assays

for Inherited Disease Testing

Number of Tests

Exhibit 5: Projected Inherited Disease Testing

by Molecular Diagnostics in U.S. 2003-2013

Exhibit 6: Trending in Projected Number of Inherited Disease Tests

by Molecular Diagnostics in U.S. 2003-2013

Exhibit 7: Trending in Percentage Distribution of Inherited Disease Tests

by Molecular Diagnostics in U.S. 2003-2013

Exhibit 8: Trending in Projected Test Volume

for Molecular Diagnostics in Inherited Disease Testing in U.S. 2003-2013

Exhibit 9: Trending in Projected Test Volume Composition

for Molecular Diagnostics in Inherited Disease Testing in U.S. 2003-2013

Market and Cost per Test Projections, 2003-2013

Exhibit 10: Projected Molecular Diagnostics Inherited Disease Testing

Market Potential in U.S. 2003-2013

Exhibit 11: Trending in Projected Market Potential

for Molecular Diagnostics in Inherited Disease Testing in U.S. 2003-2013

Exhibit 12: Trending in Projected Market Potential Composition

for Molecular Diagnostics in Inherited Disease Testing in U.S. 2003-2013

Exhibit 13: Trending in Projected Estimated Cost Per Test (ECPT)

for Molecular Diagnostics in Inherited Disease Testing in U.S. 2003-2013

 

Major Competitors

Abbott Diagnostics (Division of Abbott Laboratories)

Affymetrix, Inc.

Applied Biosystems Group (Division of Applera Corporation)

Celera Genomics/Celera Diagnostics  (Division of Applera Corporation)

Cepheid, Inc.

diaDexus, LLC

Illumina, Inc.

Innogenetics NV

Myriad Genetics, Inc.

Nanogen, Inc.

Orchid BioSciences, Inc.

Sequenom Genetic Systems  (Division of Sequenom)

Vysis (Subsidiary of Abbott Laboratories)

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    In Vitro Diagnostic Tests and Systems: The World Outside the United States

    $596.00 – $1,192.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per...Cosmetic Surgery Market: Procedure Volumes and Fees for the Top Five Procedures,...
Scroll to top